Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49672
Title: Interpreting protein dose trials in critical illness: a guide for the bedside clinician
Authors: Chapple, Lee-anne
Bels, Julia
Lee, Zheng-Yii
Summers, Matthew
Ferrie, Suzie
Stoppe, Christian
MESOTTEN, Dieter 
Deane, Adam
van de Poll, Marcel C. G.
Ridley, Emma
Issue Date: 2026
Publisher: BMC
Source: Critical Care, 30 (1) (Art N° 352)
Abstract: Background Critical illness induces a catabolic state, associated with profound muscle wasting and functional disability in survivors. Based on evidence at the time of development, international critical care nutrition guidelines recommend providing higher protein doses than in healthy populations. Main body Three recent international multi-centre randomised trials (total n = 5633 patients) have compared higher protein doses to usual protein doses in critically ill patients. Based on the primary outcomes, these trials concluded that higher protein doses did not improve time-to-discharge alive or number of days free of the index hospital and alive at day 90, with worse functional recovery using the EQ-5D-5L health utility score over 180 days. Supported by evidence from recent trials, it appears preferable to commence protein delivery at low doses once patients are haemodynamically stable and increase progressively over the first 5 days to deliver a maximum of 1.2 g/kg/day. Based on current trial data, this upper limit may represent a safer alternative to doses >1.2 g/kg/day, acknowledging that the optimal dose may be lower. Subgroup analyses suggest that patients with an acute kidney injury may be particularly vulnerable to higher protein. There are no data to indicate the minimum protein dose that can be safely delivered to critically ill patients over their entire ICU stay. While existing trials included patients with a prolonged ICU stay, no trial identifying this cohort pre-randomisation has been conducted. It cannot be excluded that higher protein doses may provide benefit later in recovery, when the anabolic resistance to dietary protein observed early in the ICU admission has subsided. Evidence is also lacking on optimal protein targets for patients after ICU discharge. Conclusion In critically ill adults, we suggest that protein doses be commenced at a low dose and increased progressively to a maximum of 1.2 g/kg/day based on recent randomised trials.
Notes: Chapple, LA (corresponding author), Adelaide Univ, Coll Hlth, Sch Med, Adelaide, SA, Australia.; Chapple, LA (corresponding author), Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA, Australia.
lee-anne.chapple@adelaide.edu.au
Keywords: Protein;Protein;Intensive care;Intensive care;Nutrition;Nutrition;Enteral nutrition;Enteral nutrition;Critical care;Critical care
Document URI: http://hdl.handle.net/1942/49672
ISSN: 1364-8535
e-ISSN: 1466-609X
DOI: 10.1186/s13054-026-06116-4
ISI #: 001811789200001
Rights: Crown 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
s13054-026-06116-4.pdfPublished version1.24 MBAdobe PDFView/Open
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.